Inventor

Antony Bigot

Inventor
Massy, FR

Overview

23→
Patents
2002–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 23 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds45%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61KPreparations for medical, dental or toiletry purposes10%
Y02PClimate change mitigation technologies in the production or processing of goods8%
C04BLime, magnesia2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C07HSugars2%
PatentTitleYear
10,941,139Cryptophycin compounds and conjugates, their preparation and their therapeutic use20218,865,906'Process for the preparation of a compound useful as an inhibitor of TAFIa'20148,314,244'Method for preparing activated esters'20128,207,355'Method for preparing azetidine derivatives'20128,119,813'Method for preparing enantiomerically enriched N-carboxyanhydride'20127,884,123'Substituted thieno[2,3-c]pyrazoles, process for preparing them, compositions containing them, and use thereof'20117,589,117'Isoindolone derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them'20097,579,366'Epothilone derivatives and their synthesis and use'20097,348,434'4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them'20087,265,111'Adenosine analogues and their use as pharmaceutical agents'20077,232,834'Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor'20077,232,833'4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them'20077,227,022'Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase'20077,078,428'Isoindolone derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them'20066,953,796'Use of 2-amino-thiazoline derivatives as inhibitors of inducible No-synthase'20056,872,740'Use of 2-amino-4-heteroarylethyl-thiazoline derivatives as inhibitors of inducible no-synthase'20056,841,562'Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor'20056,762,196'Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase'20046,699,867'Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase'20046,699,895'2-aminothiazoline derivatives and process for preparing the same'20046,531,497'Epothilone derivatives and their synthesis and use'20036,451,821'Use of 2-aminothiazoline derivatives as inhibitors of inducible no-synthase'20026,420,566'Pharmaceutical compositions containing a 4, 5-dihydro-1, 3-thiazol-2-ylamine derivative, novel derivatives and preparation thereof'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2011Patents assigned to AVENTIS PHARMA SA (10)· patent assignee history
2002–2011Based in Massy, FR· patent location history
2003–2021Based in Paris, FR· patent location history
2006–2009Patents assigned to SANOFI AVENTIS DEUTSCHLAND (3)· patent assignee history
2007Based in Vitry sur Seine, FR· patent location history
2008–2014Patents assigned to BIGOT ANTONY (5)· patent assignee history
2012–2021Patents assigned to SANOFI SA (3)· patent assignee history
2012Patents assigned to LAMPILAS MAXIME (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AVENTIS PHARMA SA102002–2011
BIGOT ANTONYself52008–2014
SANOFI AVENTIS DEUTSCHLAND32006–2009
SANOFI SA32012–2021
LAMPILAS MAXIME22012
Locations
LocationPatentsSpan
Massy, FR152002–2011
Paris, FR72003–2021
Vitry sur Seine, FR12007